Cogent Biosciences Inc’s filing revealed that its Director Fairmount Funds Management LLC acquired Company’s shares for reported $25.0 million on Jul 10 ’25. In the deal valued at $9.00 per share,2,777,777 shares were bought. As a result of this transaction, Fairmount Funds Management LLC now holds 9,003,418 shares worth roughly $117.49 million.
Then, Pinnow Cole bought 43,750 shares, generating $332,412 in total proceeds. Upon buying the shares at $7.60, the Chief Commercial Officer now owns 45,848 shares.
Raymond James initiated its Cogent Biosciences Inc [COGT] rating to a Strong buy in a research note published on September 03, 2025; the price target was $30. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early March with a ‘”a Sector outperform”‘ rating. Needham also remained covering COGT and has decreased its forecast on December 11, 2024 with a “Hold” recommendation from previously “Buy” rating. Robert W. Baird revised its rating on February 26, 2024. It rated COGT as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of COGT
On Friday, Cogent Biosciences Inc [NASDAQ:COGT] saw its stock jump 0.85% to $13.05. Over the last five days, the stock has gained 8.03%. Cogent Biosciences Inc shares have risen nearly 19.18% since the year began. Nevertheless, the stocks have risen 67.31% over the past one year. While a 52-week high of $13.50 was reached on 09/03/25, a 52-week low of $3.72 was recorded on 04/09/25.
Levels Of Support And Resistance For COGT Stock
The 24-hour chart illustrates a support level at 12.83, which if violated will result in even more drops to 12.60. On the upside, there is a resistance level at 13.22. A further resistance level may holdings at 13.38.
How much short interest is there in Cogent Biosciences Inc?
A steep rise in short interest was recorded in Cogent Biosciences Inc stocks on 2025-08-15, dropping by -0.75 million shares to a total of 13.01 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 13.76 million shares. There was a decline of -5.76%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 08, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
